A partnership of the lipid scramblase XK and of the lipid transfer protein VPS13A at the plasma membrane

Andrés Guillén-Samander, Yumei Wu, S. Sebastian Pineda, F. García, Julia N. Eisen, Marianna Leonzino, Berrak Uğur, Manolis Kellis, Myriam Heiman, Pietro De CamillibioRxiv 2022 · DOI

Abstract

Chorea-acanthocytosis and McLeod syndrome are neurodegenerative disorders caused by mutations in VPS13A and XK, respectively. While clinically similar, the molecular link between these two proteins remained unclear. This study demonstrates that VPS13A, an ER-anchored lipid transfer protein, localizes to ER-plasma membrane (PM) contacts by binding the scramblase XK. This interaction is mediated by the VPS13A PH domain and is competitive with its binding to other organelles. These findings suggest a model where bulk lipid transfer is coupled with membrane scrambling, providing a unified mechanism for the pathogenesis of these diseases.

The Problem: A Shared Clinical Fate

The human body relies on precise lipid distribution across cellular membranes. Two rare but devastating neurodegenerative diseases—Chorea-acanthocytosis (ChAc) and McLeod syndrome (MLS)—result from mutations in the proteins VPS13A and XK, respectively. Despite having different genetic causes, the diseases are clinically indistinguishable, characterized by the death of neurons in the brain's movement centers (the caudate nucleus) and misshapen red blood cells.

Scientists knew these proteins were functional partners, but the "where" and "how" remained elusive. VPS13A was known to act as a bridge, moving lipids from the ER to mitochondria or lipid droplets. However, XK resides at the plasma membrane. This paper addresses the missing link: how does an ER-anchored protein (VPS13A) interact with a PM-resident protein (XK), and what does this partnership actually do?

Structural Insights and Dual Localization

Using AlphaFold2, the researchers modeled VPS13A as a massive 22nm rod with a hydrophobic groove designed for bulk lipid transport. This structure acts like a "bridge" or "slide," allowing lipids to flow between membranes without entering the watery cytoplasm.

Figure 1: VPS13A domain architecture and its dual localization to mitochondria and ER-PM contacts via XK.

The study revealed that VPS13A's C-terminal Pleckstrin Homology (PH) domain acts as a specific "hook" that can bind either to mitochondria or to the second cytosolic loop (L2) of XK at the PM. This dual targeting suggests that the cell can "toggle" VPS13A between different organelles depending on physiological needs.

The VPS13A-XK Interaction Mechanism

The interaction is highly specific and regulated. The researchers discovered that XK possesses an internal "lock" mechanism where its L2 and L3 loops interact, hiding the VPS13A binding site. When this interaction is disrupted—either by specific mutations or potentially by a yet-unknown physiological signal—XK "opens up," robustly recruiting VPS13A to the plasma membrane.

Figure 4: The VPS13A PH domain mediates binding to both mitochondria and XK, as shown by colocalization and chemically induced clustering experiments.

Chemically induced clustering of XK at the PM directly recruited VPS13A in real-time, confirming their physical association in live cells. This recruitment competes with VPS13A's localization to mitochondria, providing a mechanism for the protein to switch between different tethering functions.

Coupling Transfer to Scrambling

XK is a scramblase—it flips lipids between the inner and outer layers of a single membrane. The authors propose a model where VPS13A delivers lipids from the ER to the inner layer of the PM, and XK immediately "scrambles" them to the outer layer. This ensures the membrane expands or changes composition evenly, a process likely critical for the health of Medium Spiny Neurons (MSNs) in the human caudate nucleus, where both proteins are highly expressed.

Future Directions

While the study identifies the molecular bridge, the "key" that naturally unlocks XK remains unknown. Furthermore, proving that defective cell surface exposure of specific lipids, like Phosphatidylserine, directly causes neurodegeneration is a major next step in understanding and potentially treating ChAc and MLS.

Summary updated

Abstract

Chorea-acanthocytosis and McLeod syndrome are diseases with shared clinical manifestations caused by mutations in VPS13A and XK, respectively. Key features of these conditions are the degeneration of caudate neurons and the presence of abnormally shaped erythrocytes. XK belongs to a family of plasma membrane (PM) lipid scramblases whose action results in exposure of PtdSer at the cell surface. VPS13A is an ER-anchored lipid transfer protein with a putative role in the transport of lipids at contacts of the ER with other membranes. Recently VPS13A and XK were reported to interact by still unknown mechanisms. So far, however, there is no evidence for a colocalization of the two proteins at contacts of the ER with the PM, where XK resides, as VPS13A was shown to be localized at contacts between the ER and either mitochondria or lipid droplets. Here we show that VPS13A can also localize at ER-PM contacts via the binding of its PH domain to a cytosolic loop of XK, that such interaction is regulated by an intramolecular interaction within XK and that both VPS13A and XK are highly expressed in the caudate neurons. Binding of the PH domain of VPS13A to XK is competitive with its binding to intracellular membranes that mediate other tethering functions of VPS13A. Our findings support a model according to which VPS13A-dependent lipid transfer between the ER and the PM is coupled to lipid scrambling within the PM. They raise the possibility that defective cell surface exposure of PtdSer may be responsible for neurodegeneration.
BibTeX
@misc{guillensamander2022partnership,
  author = {Andrés Guillén-Samander and Yumei Wu and S. Sebastian Pineda and F. García and Julia N. Eisen and Marianna Leonzino and Berrak Uğur and Manolis Kellis and Myriam Heiman and Pietro De Camilli},
  title = {{A partnership of the lipid scramblase XK and of the lipid transfer protein VPS13A at the plasma membrane}},
  year = {2022},
  doi = {10.1101/2022.03.30.486314},
  howpublished = {bioRxiv},
}
Figure